← Leaderboards
Leigh Meredith Howard
Vanderbilt University Medical Center
$1,221,592
Attributed
$1,706,766
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $486.3K · FY2019–24$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,706,766 · 3
By mechanism
R21$970,349 · 2
K23$736,417 · 1
Top collaborators
- Carlos G Grijalva4 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Keith T Wilson$21,094,933
- Carlos G Grijalva$7,760,476
- Christian Rosas-Salazar$2,810,762
- Jessica L Castilho$5,935,018
Others in their field
Other Emerging Leaders on “Infection”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$207,651,224
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
InfectionSamplingRespiratoryHouseholdVaccinationRespiratory VirusPatternChildPathogenesisRespiratory Tract InfectionsSuccessAcuteBacteriaStreptococcus PneumoniaeReportingPeruPneumoniaNosePathogenicityPneumococcal ColonizationCo-InfectionPreventDetectionVaccines
Grant awards (8)
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease$224,548
R21 · FY2024 · AI · contact PI
Human rhinovirus infection and susceptibility to SARS-CoV-2 infection and symptomatic disease$270,051
R21 · FY2023 · AI · contact PI
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes$216,250
R21 · FY2023 · AI · contact PI
Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes$259,500
R21 · FY2022 · AI · contact PI
Pneumococcal dynamics in the conjugate vaccine era: Addressing unanswered questions$184,307
K23 · FY2022 · AI · contact PI
Pneumococcal dynamics in the conjugate vaccine era: Addressing unanswered questions$183,906
K23 · FY2021 · AI · contact PI
Pneumococcal dynamics in the conjugate vaccine era: Addressing unanswered questions$183,027
K23 · FY2020 · AI · contact PI
Pneumococcal dynamics in the conjugate vaccine era: Addressing unanswered questions$185,177
K23 · FY2019 · AI · contact PI